Literature DB >> 1753808

Longitudinal Gompertzian analysis of prostate cancer mortality in the U.S., 1962-1987: a method of demonstrating relative environmental, genetic and competitive influences upon mortality.

J E Riggs1.   

Abstract

Age-specific mortality rates for prostate cancer (PC) in the United States from 1962 to 1987 were subjected to longitudinal Gompertzian analysis. Age-specific PC mortality rate distributions between age 55 and 85 years were determined by a variable competitive factor and a common intersect point. The intersect point for PC occurred at age 61.5 years and mortality rate 27.9 per 100,000 and reflects genetic and environmental influences upon mortality. Between 1962 and 1987, non-age-standardized annual crude PC mortality rates increased 41.6%. Longitudinal Gompertzian analysis suggests that rising PC mortality rates in the United States are the natural consequence of competitive deterministic mortality dynamics. Moreover, longitudinal Gompertzian analysis is a method that demonstrates the relative contribution of environmental, genetic and competitive influences upon disease specific mortality.

Entities:  

Mesh:

Year:  1991        PMID: 1753808     DOI: 10.1016/0047-6374(91)90037-z

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

1.  Cellular aging, destabilization, and cancer.

Authors:  H Rubin; M Chow; A Yao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

2.  Unmasking large and persistent reductions in proliferation rate of aging cells.

Authors:  M Chow; M Kong; H Rubin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Nov-Dec       Impact factor: 2.723

Review 3.  Targeting immunometabolism as an anti-inflammatory strategy.

Authors:  Eva M Pålsson-McDermott; Luke A J O'Neill
Journal:  Cell Res       Date:  2020-03-04       Impact factor: 25.617

4.  Within- and between-strain variability in longevity of inbred and outbred rats under the same environmental conditions.

Authors:  O Ghirardi; R Cozzolino; D Guaraldi; A Giuliani
Journal:  Exp Gerontol       Date:  1995 Sep-Oct       Impact factor: 4.032

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.